Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

June
19
2026

Are Skin Cancer Risk Factors Different for Men and Women?

Skin cancer usually starts from spending too much time under the sun’s powerful ultraviolet (UV) rays. Without protecting your skin from these rays, they can damage your DNA – which controls how your cells grow…

March
15
2022

Everything You Need to Know About the Transdermal Infusion System

In December of 2021, Sensus Healthcare announced the arrival of a new alternative to medical and aesthetic injections called TransDermal Infusion®. Approved by the FDA as a Class II biophysical alternative to infusing high weight…

March
09
2022

Sensus Healthcare to Present at Two Investment Conferences in March

BOCA RATON, Fla. , March 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will…

March
09
2022

Sensus Healthcare Announces Share Repurchase Program

BOCA RATON, Fla, March 09, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of…

March
02
2022

Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March 02, 2022 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly…

Archives
Archives

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry